Validation of the nucleotide excision repair comet assay on cryopreserved PBMCs to measure inter-individual variation in DNA repair capacity
| Autor: | Simonetta Guarrera, Kim Vande Loock, Alessandra Allione, Floriana Voglino, Fulvio Ricceri, Giuseppe Matullo, Alessia Russo, Micheline Kirsch-Volders |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2012 |
| Předmět: |
Aphidicolin
DNA Repair DNA repair Health Toxicology and Mutagenesis Coefficient of variation Biology Toxicology Peripheral blood mononuclear cell Nucleotide excision repair comet validation DNA repair capacity Cell Line 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Genetics Humans Genotyping Genetics (clinical) Carcinogen 030304 developmental biology 2. Zero hunger Cryopreservation 0303 health sciences Molecular biology 3. Good health Comet assay chemistry 030220 oncology & carcinogenesis Leukocytes Mononuclear Comet Assay Mutagens |
| Zdroj: | Mutagenesis |
| ISSN: | 1464-3804 0267-8357 |
| DOI: | 10.1093/mutage/ges054 |
| Popis: | Inter-individual susceptibility to mutagens/carcinogens can be assessed by either genotyping DNA repair genes in different pathways or phenotyping DNA repair capacity (DRC) at the molecular or cellular level. Due to the large number of known DNA repair genes, and the interactions between repair pathways, phenotyping is becoming the preferred approach to measure DRC, and reliable assays are therefore increasingly needed. The use of a cellular phenotype comet assay for the nucleotide excision repair (NER) pathway using benzo[a]pyrene diol epoxide (BPDE) has been described in previous papers, but no thorough evaluation of its applicability in large genotype-phenotype studies has been presented. Our aim was to evaluate the possibility of using cryopreserved instead of fresh peripheral blood mononuclear cells (PBMCs) to evaluate intra- and inter-assay variation, and inter-individual variation, for the aphidicolin (APC)-block NER comet assay. Moreover, we measured the variation for the designated internal standard (K562 erythroleukaemia cell line) and we evaluated the feasibility to use lymphoblastoid cell lines (LCLs) as surrogate of PBMCs. Our results showed a low intra-assay [coefficient of variation (CV) 19.9%] and inter-assay (CV 32.3%) variation, with a good inter-individual variation (122 subjects, mean ± standard deviation 7.38 ± 4.99; range 0.66-26.14; CV 67.63%). A significant correlation between results derived from cryopreserved and fresh PBMCs from the same individuals was found (10 subjects, r = 0.62, P = 0.05). Results from LCLs and cryopreserved PBMCs from the same subjects showed an inverse significant correlation (10 subjects, r = -0.712, P = 0.02). K562 cells as internal standard showed low intra-assay variation. In the present study the APC-block NER comet assay on cryopreserved PBMCs seemed to be a reliable method to measure DRC variation in epidemiological studies; LCLs were not a good surrogate in this assay. This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro (Italy; G.M.), the Progetto Integrato Oncologia, Regione Toscana—Ministero della Salute ‘Identification of population risk profiles as an approach to cancer prevention’ and the Environmental Cancer Risk Nutrition and Individual Susceptibility project (G.M., M.K.V.), a network of excellence operating within the European Union Sixth Framework Program, Priority 5: ‘Food Quality and Safety’ (Contract No. 513943). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|